Lisa Peraza - 18 Jan 2023 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Signature
/s/ Lisa Peraza
Issuer symbol
HRTX
Transactions as of
18 Jan 2023
Net transactions value
$0
Form type
4
Filing time
20 Jan 2023, 16:09:01 UTC
Previous filing
17 Jan 2023
Next filing
17 Apr 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Performance Stock Units Award $0 +42,631 $0.000000 42,631 18 Jan 2023 Common Stock 42,631 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested.